AU2002214132A1 - Vector system for transducing the positive neurons - Google Patents
Vector system for transducing the positive neuronsInfo
- Publication number
- AU2002214132A1 AU2002214132A1 AU2002214132A AU1413202A AU2002214132A1 AU 2002214132 A1 AU2002214132 A1 AU 2002214132A1 AU 2002214132 A AU2002214132 A AU 2002214132A AU 1413202 A AU1413202 A AU 1413202A AU 2002214132 A1 AU2002214132 A1 AU 2002214132A1
- Authority
- AU
- Australia
- Prior art keywords
- transducing
- vector system
- positive neurons
- neurons
- positive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000002569 neuron Anatomy 0.000 title 1
- 230000002463 transducing effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6072—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
- C12N2810/6081—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0026943.1 | 2000-11-03 | ||
| GB0026943A GB0026943D0 (en) | 2000-11-03 | 2000-11-03 | Vector system |
| GB0102339A GB0102339D0 (en) | 2001-01-30 | 2001-01-30 | Vector system |
| GB0102339.9 | 2001-01-30 | ||
| GB0122238.9 | 2001-09-14 | ||
| GB0122238A GB0122238D0 (en) | 2001-09-14 | 2001-09-14 | Vector system |
| PCT/GB2001/004866 WO2002036170A2 (en) | 2000-11-03 | 2001-11-02 | Vector system for transducing the positive neurons |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002214132A1 true AU2002214132A1 (en) | 2002-05-15 |
Family
ID=27255961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002214132A Abandoned AU2002214132A1 (en) | 2000-11-03 | 2001-11-02 | Vector system for transducing the positive neurons |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040071675A1 (https=) |
| EP (1) | EP1333863A2 (https=) |
| JP (2) | JP2004517057A (https=) |
| AU (1) | AU2002214132A1 (https=) |
| WO (1) | WO2002036170A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003025188A1 (en) * | 2001-09-14 | 2003-03-27 | Oxford Biomedica (Uk) Limited | Use of a lentiviral vector in the treatment of pain |
| FR2841246B1 (fr) * | 2002-06-20 | 2004-12-31 | Centre Nat Rech Scient | Peptide issu de la proteine g du virus de la rage, ligand du recepteur de basse affinite des neurotrophines(p75ntr) et ses applications |
| JP2006502240A (ja) * | 2002-10-04 | 2006-01-19 | オックスフォード バイオメディカ (ユーケー) リミテッド | ベクター系 |
| CA2943039C (en) | 2005-10-14 | 2018-11-06 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Rabies virus compositions and methods |
| EP2239330A1 (en) | 2009-04-07 | 2010-10-13 | Institut Pasteur | Neuron generation, regeneration and protection |
| JP5123922B2 (ja) * | 2009-12-02 | 2013-01-23 | 独立行政法人科学技術振興機構 | 融合糖タンパク質から成るエンベロープを有する逆行性輸送ウィルスベクター系 |
| JP5216072B2 (ja) * | 2010-11-26 | 2013-06-19 | 独立行政法人科学技術振興機構 | 神経細胞特異的な逆行性輸送ベクター |
| EP3466443B1 (en) | 2012-02-14 | 2020-12-16 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom |
| WO2016054079A1 (en) | 2014-09-29 | 2016-04-07 | Zyomed Corp. | Systems and methods for blood glucose and other analyte detection and measurement using collision computing |
| CA2966191A1 (en) * | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5817491A (en) * | 1990-09-21 | 1998-10-06 | The Regents Of The University Of California | VSV G pseusdotyped retroviral vectors |
| WO1999061639A2 (en) * | 1998-05-22 | 1999-12-02 | Oxford Biomedica (Uk) Limited | Retroviral delivery system |
| US20040076613A1 (en) * | 2000-11-03 | 2004-04-22 | Nicholas Mazarakis | Vector system |
| US6818209B1 (en) * | 1998-05-22 | 2004-11-16 | Oxford Biomedica (Uk) Limited | Retroviral delivery system |
| EP0961830A1 (en) * | 1997-01-29 | 1999-12-08 | Neurosearch A/S | EXPRESSION VECTORS AND METHODS FOR $i(IN VIVO) EXPRESSION OF THERAPEUTIC POLYPEPTIDES |
-
2001
- 2001-11-02 EP EP01982589A patent/EP1333863A2/en not_active Ceased
- 2001-11-02 AU AU2002214132A patent/AU2002214132A1/en not_active Abandoned
- 2001-11-02 WO PCT/GB2001/004866 patent/WO2002036170A2/en not_active Ceased
- 2001-11-02 JP JP2002538979A patent/JP2004517057A/ja active Pending
-
2003
- 2003-05-05 US US10/429,608 patent/US20040071675A1/en not_active Abandoned
-
2008
- 2008-05-20 JP JP2008131960A patent/JP2008303215A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1333863A2 (en) | 2003-08-13 |
| US20040071675A1 (en) | 2004-04-15 |
| WO2002036170A2 (en) | 2002-05-10 |
| WO2002036170A3 (en) | 2002-08-22 |
| JP2004517057A (ja) | 2004-06-10 |
| JP2008303215A (ja) | 2008-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002218623A1 (en) | Robot system | |
| AU2002218627A1 (en) | Robot system | |
| AU6607700A (en) | Robotic system | |
| AU2001239746A1 (en) | Group-browsing system | |
| AUPP971499A0 (en) | On-line electoral system | |
| AU4192199A (en) | Proposal based architecture system | |
| AU2297001A (en) | Telestrator system | |
| AUPQ802400A0 (en) | Propulsion system | |
| AU6232800A (en) | On-line higher education financing system | |
| AU1335900A (en) | Transformation vector system | |
| AU2001232054A1 (en) | Vector | |
| AU2495300A (en) | Lentivirus vector system | |
| AU2002214132A1 (en) | Vector system for transducing the positive neurons | |
| AU2001252758A1 (en) | Online relay-broadcasting system | |
| AU2001284775A1 (en) | Anti-balling system | |
| AU5216601A (en) | Reconnaissance system | |
| AU2001277213A1 (en) | High-availability shared-memory system | |
| AU4868201A (en) | Tracking system | |
| AU2001289885A1 (en) | Air-preparation system | |
| AU2003271883A1 (en) | Vector system | |
| AUPQ009199A0 (en) | Wetsuit | |
| AU2001285846A1 (en) | Learning system | |
| AU7764400A (en) | Product verification system | |
| AU2001293667A1 (en) | Buckle-fastener system | |
| AU6795501A (en) | Modelling system |